FosB is a member of the Activator Protein-1 (AP-1) transcription factor family that regulates gene expression in response to extracellular stimuli
[1][2]. Mechanistically, FosB integrates signals from pathways including P2RX7 nucleotide receptor activation, TGF-β signaling, and IL-1-mediated inflammatory pathways, modulating cellular proliferation, differentiation, migration, and osteogenic or immune responses
[1][3]. In disease models, FosB isoforms such as ΔFosB exhibit region-specific effects in the brain, influencing reward circuitry, stress response, and cognitive function in addiction, depression, and Parkinson’s disease
[4][5][6]. Compared with related Fos isoforms, ΔFosB demonstrates enhanced nuclear stability and prolonged transcriptional activity, which allows sustained regulation of target genes including GluA2, parkin, and COX-2
[4][5][1]. FosB also forms heterodimeric complexes with other transcription factors such as NFATc3 to regulate tissue factor expression and monocyte trafficking in inflammatory models
[7]. Functionally, pharmacological or genetic manipulation of FosB or ΔFosB alters migration, invasion, and fibrosis-related pathways, highlighting their utility as targets in neurodegeneration and cancer research
[8][3]. Isoform-specific transcriptional activity and inducibility make FosB a critical node in linking extracellular signals to downstream gene networks, offering mechanistic insight for experimental designs involving transcriptional regulation, stress response, and tissue-specific pathology
[1][2].